Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Purchase
Common Stock
2025-11-11$18.64/sh+10,700$199,403→ 23,702 total
Footnotes (1)
- [F1]The price reported in column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $18.55 to $18.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.